Introduction
Neural progenitor cells (NPCs) undergo self-renewal and differentiation into neuronal and glial lineages and considered as a promising cell source for the treatment of central nervous system disorders such as Parkinson's disease (Dyson et al., 2011) , spinal cord injury (Tetzlaff et al., 2011) , and traumatic brain injury (Gögel et al., 2011) . NPCs isolated from fetal human brain tissues have been transplanted for the treatment of a patient with Parkinson's disease (Freed et al., 2001) . However, the limitation of donor cells and ethical concerns make this therapy difficult to clinically apply. Embryonic stem (ES) cells and induced pluripotent stem (iPS) cells are other candidate cell sources for stem cell-based transplantation therapies (Robinton et al., 2012) . These cells can unlimitedly proliferate in vitro and differentiate into multiple types of functional cells. Recently, two clinical trials using human ES-derived cells were started (Solbakk et al., 2011; Schwartz et al., 2012) . In addition, iPS-derived cells may be useful for studying the mechanisms underlying the progression of central nervous system disorders and for developing effective treatments for associated diseases (Bellin et al., 2012) .
Various protocols have been reported for the differentiation of iPS cells into a neural lineage (Czepiel et al., 2011; Cai, et al., 2010; Selvaraj et al., 2012) . It was also reported that neural cells derived from iPS cells had been successfully integrated into the animal brain and spinal cord (Nori et al., 2011; Rhee et al., 2011) . iPS cell-derived neural cells improved the motor function of the animals to a certain degree. Although neural cells derived from pluripotent stem cells are considered to have utility in cell replacement therapy, various difficulties still remain to be overcome. First, graft rejection by the host immune system is unavoidable in transplantation therapy and should be carefully controlled. When cells derived from ES cells are used, the graft is expected to be recognized as allogeneic tissue and thus will be rejected by the host immune system (Bradley et al., 2002; Drukker et al., 2004; Taylor et al., 2011) . Even when iPS cells are derived from a patient, however, the reprogramming protocols may affect the immunogenicity of the grafts (Taylor et al., 2011) . Second, tumor formation must be carefully considered in cell transplantation therapy using iPS-derived cells (Hentze et al., 2010; Fong et al., 2010) . Undifferentiated pluripotent stem cells and progenitor cells contained in transplants may proliferate and overgrow in the host brain (Li et al., 2008) .
Most of the applications mentioned above require an in vitro culture that allows the proliferation of NPCs without altering their properties. Extracellular matrices (ECMs) play pivotal roles in the maintenance of various stem and progenitor cells in native tissues and in the behaviors of neural cells (Wojcik-Stanaszek et al., 2011) . In the present study, protein arrays (Soen et al., 2006; Nakajima et al., 2007) were fabricated with various ECMs and used to screen for the proliferation of NPCs derived from mouse iPS (miPS) cells. Array-based assays enable high-throughput screening of substrates with immobilized proteins and synthetic polymers (Little et al., 2011; Derda et al., 2007; Derda et al., 2010) . Based on the results of the ECM screening, globular domain 3 (LG3), a part of the laminin 1 chain, was synthesized as a fusion with a hexahistidine sequence (Histag).
LG3 is relatively small domain (16.5 kDa) and known to efficiently bind with 61 integrin (Ido et al., 2004) . The engineered protein was anchored through the coordination of 6 the His-tag with Ni 2+ ions bound on a glass plate, and feasibility of the substrate with surface-immobilized LG3 was examined for the proliferation of NPCs.
Materials and Methods

Maintenance of miPS cells and their differentiation into NPCs
miPS cells (20D17) (Okita et al., 2007) were obtained from the Riken cell bank (Ibaraki, Japan). The cells had been transformed to express GFP driven by the promoter of Nanog. miPS cells maintained on a feeder layer of mouse embryonic fibroblasts in DMEM (Invitrogen Corp., Carlsbad, CA, USA) containing 15% fetal bovine serum, 0.1 mM MEM non-essential amino acids, 0.1 mM 2-mercaptoethanol, 1000 U/mL leukemia inhibitory factor (Millipore, Billerica, MA, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin. The cells were seeded to a gelatin-coated dish and incubated for 40 min to allow for depleting feeder cells possibly present in a population, and then unattached miPS cells were recovered for the later experiments.
The neurosphere method was used to induce neural cells from miPS cells (Okada et al., 2008) . miPS cells were suspended in DMEM/F12 (1:1) containing 2% (v/v) B27 supplement (Invitrogen), 5 μg/mL heparin, 100 U/mL penicillin, and 100 μg/mL streptomycin (hereafter referred to as base medium) supplemented with 20 ng/mL epidermal growth factor (EGF, Wako Pure Chemical Industries, Osaka, Japan), 20 ng/mL basic fibroblast growth factor (bFGF, Wako), and 10 nM retinoic acid (Sigma, St. Louis, MO, USA), and then plated at a density of 8.5×10 
Preparation of ECM arrays
ECMs were covalently immobilized onto the glass surface. First, amine groups were introduced on the surface of glass plates (22 mm × 26 mm × 0.5 mm) by treating with aminopropyltriethoxysilane (APTES; Shin-Etsu Chemical Co., Ltd., Tokyo, Japan) (Konagaya et al., 2011) . These plates were immersed in 10% (v/v) aqueous glutaraldehyde solution for 1 h at room temperature to introduce aldehyde groups. After washing the plates with water, a silicone frame with multiple circular windows (2 mm in diameter, 5 × 4 windows) was mounted on top of each glass plate to make a microwell array. ECM solutions in phosphate-buffered saline (PBS) containing 50 μg/mL collagen I (Cellmatrix type I, porcine tendon, Nitta Gelatin, Inc., Osaka, Japan), 50 μg/mL collagen IV (Cellmatrix type IV, bovine crystalline lens, Nitta Gelatin, Inc.), 50 μg/mL gelatin (porcine skin, Sigma), 50 μg/mL laminin-1 (mouse Engelbreth-Holm-Swarm sarcoma, Invitrogen), 50 μg/mL Matrigel (mouse Engelbreth-Holm-Swarm sarcoma, BD Biosciences, San Jose, CA, USA), 50 μg/mL fibronectin (human serum, BD Biosciences), 50 μg/mL vitronecitn (Sigma), 50 μg/mL ProNectin F (synthetic ECM, Sanyo Chemical Industries Ltd., Kyoto, Japan), or 2 μg/mL laminin-5 (human recombinant, Oriental Yeast Co., Ltd., Tokyo, Japan) were separately pipetted into different wells on a single array (15 μL for each well). Among the ECMs used, ProNectin F is a commercially available synthetic ECM consisting of celladhesive arginine-glycine-aspartic acid (RGD) residues connected with β-sheet-forming hydrophobic segments. All ECMs were immobilized on the glass surface through Schiff base formation between aldehydes and amines contained in proteins. After 1 h, the ECM array was washed with PBS to remove unbound proteins. As a control surface, PBS containing 1 M ethanolamine was used instead of protein solutions. Ethanolamine was used to block unreacted aldehyde groups of the glass surface. Summary of the preparation of ECM array was shown in supporting figure 1.
Amounts of immobilized ECM proteins
ECMs were separately immobilized onto the surfaces of glass plates (22 mm × 26 mm × 0.5 mm) through the method similar to that described above. The amounts of immobilized ECM proteins were determined using the Micro BCA Protein Assay Kit (Thermo, Waltham, MA, USA). A silicone frame with a square window (inner area: 4 cm 2 ) was placed on the ECM-immobilized surface. The Micro BCA reaction mixture (150 L) was pipetted into the window, and the temperature was maintained at 37 C for 2 h to allow for the color reaction. The absorbance of the resulting solution was measured at 562 nm using a spectrophotometer (SpectraMax TM 2Me, Molecular Devices, LLC, Sunnyvale, CA, USA). The amount of immobilized protein was determined using bovine serum albumin as a standard.
Array-based assays
NPC-containing cell aggregates of 4th generation were dissociated into single cells by treatment with AccuMax containing 0.05% trypsin. The cells were suspended in base medium supplemented with 20 ng/mL EGF and 20 ng/mL bFGF (Okada et al., 2008) Olympus Optical Co., Ltd., Tokyo, Japan). Cells reactive for antibodies to nestin were counted on the merged images with nuclei staining. The original images were recorded at a magnification of 200, and individual cells were carefully identified on merged images.
Preparation of His-tagged human LG3
The preparation of human LG3 (MW = 16.5 kDa) carrying hexahistidine residues at the terminus (LG3-His) was previously reported (Nakaji et al., 2012) . Briefly, complementary DNA (cDNA) for human LG3 was obtained by polymerase chain reaction using human brain cDNA libraries (Takara Bio Inc., Shiga, Japan) as templates and specific primers. The resulting DNA fragments were extended with an N-terminal linker and a Histag sequence, and then inserted into the multiple cloning site of the pET22 vector (Millipore). The protein was expressed in Escherichia coli (BL21 codonplus strain). LG3-His, obtained as inclusion bodies, was extracted under denaturing conditions with 8 M urea, purified using a Ni 2+ -chelated affinity column (His Trap HP; GE Healthcare Bio-Science Corp., Piscataway, NJ, USA), and refolded by dialyzing against solutions in the presence of reduced and oxidized glutathione. The purity of LG3-His was checked by sodium dodecylsulfate-polyacrylamide gel electrophoresis. The concentration of LG3-His was determined using the Micro BCA Protein Assay Kit (Thermo). The solution of purified
LG3-His was stored at -80 C until use.
Immobilization of LG3-His on glass surfaces
LG3-His was immobilized on glass surfaces via chelation of Ni 2+ with the His-tag, as previously described (Konagaya et al., 2011) . Briefly, cleaned glass plates (22 mm × 26 mm × 0.5 mm; Matsunami Glass Ind. Ltd., Osaka, Japan) were immersed in 5% (v/v) APTES in toluene for 1 h at room temperature, then washed with ethanol and water. The plates were placed in a vacuum oven and heated to 80 C for 3 h to obtain glass plates surface-modified with APTES, which carries an amino group at its terminus. The APTESmodified glass plates were immersed in 10% (v/v) aqueous glutaraldehyde (Nacalai Tesque) for 30 min at room temperature to introduce aldehyde groups. The plates were then washed with water to remove unreacted glutaraldehyde. Then, a 10 mM aqueous solution of N-(5-amino-1-carboxypentyl) iminodiacetic acid (Dojindo Laboratories) was applied onto the activated surface, the plates were kept at room temperature for 2 h, and then washed with water to remove unreacted N-(5-amino-1-carboxypentyl) iminodiacetic acid. 
Statistical analysis
The data were compared by means of one-way analysis of variance (ANOVA), followed by Tukey's honestly significance difference (HSD) test. All statistical analyses were performed using the software JMP (SAS Institute Inc., NC).
Results
Induction of miPS cells into a neural linage
miPS cells used in this study had been transformed to express GFP driven by the promoter of Nanog, known as a key transcription factor to maintain cells in the undifferentiated state. miPS cells were detached from a feeder cell layer and cultured as neurosphere-like aggregates in the presence of a low concentration (10 nM) of retinoic acid to differentiate miPS cells into a neural lineage. The time schedule for differentiation is shown in Fig. 1a. Although the GFP expression level of the aggregated cells gradually decreased during the first 5 d of culture, most cells still expressed GFP and an undifferentiated marker Oct-3/4 in primary aggregates (Fig. 1 b and c) . To induce differentiation into NPCs, aggregates were dissociated into single cells and further cultured in suspension in the presence of retinoic acid. In contrast to the primary aggregates, the majority of cells in the 4th-generation aggregates expressed neither GFP nor Oct-3/4, but expressed nestin and -tubulin III, markers of NPCs and of neurons, respectively. During repeated subcultures, the NPC population was enriched, and nestin-positive cells reached more than 70% of the total cells at the end of the 4th aggregate culture (Fig. 1d) . Cells obtained from the 4th-generation aggregates were used for the following array-based assays.
Immobilization of ECM proteins
Nine ECMs (collagen I, collagen IV, gelatin, laminin-1, laminin-5, Matrigel, fibronectin, vitronectin, and ProNectin F) were separately immobilized on glass surfaces.
As shown in Fig. 2 , the amounts of immobilized ECMs after extensive washing with PBS were determined to be 0.05-0.5 μg/cm 2 . The observed low density of laminin-5 was probably caused by the low concentration (2 μg/mL) of the laminin-5 solution used, compare to the other proteins (50 μg/mL). This was simply because laminin-5 of higher concentration was not commercially available.
Array-based screening of ECMs for NPC proliferation
Fourth-generation aggregates were dissociated into single cells and seeded to the ECM array to examine the effect of ECMs on NPC proliferation. As a negative control, ethanolamine was used instead of ECMs. Figure 3 shows the number of cells adhering to various substrates with immobilized ECMs 24 h after cell seeding. As is seen, laminin-1, laminin-5, Matrigel, and fibronectin were effective for cell adhesion, but vitronectin, collagen I, collagen IV, gelatin, and ProNectin F were relatively ineffective. Fluorescence (Fig. 4b) , yielding populations rich in nestin-positive cells (more than 95% of cells). Although the amount of immobilized laminin-5 was at least 3-fold or so lower than the levels of the other ECMs (Fig. 2) , the laminin-5-immobilized surface effectively mediated adhesion and facilitated expansion of NPCs derived from miPS cells (Figs. 3 and 4) .
Expansion of NPCs on LG3-immobilized substrate
The surface with immobilized LG3 domain of a laminin 1 chain (an  chain contained in laminin-1) was examined as a culture substrate for the proliferation of NPCs because a chemically defined and xeno-free cell culture substrate will be required for future clinical applications.
LG3 was fused with a His-tag through recombinant DNA technology and immobilized onto the Ni 2+ -bound glass surface through coordination as previously reported (Konagaya et al., 2011) . The amounts of immobilized LG3-His was determined to be 0.50 ± 0.11 μg/cm 2 . Figure 5a shows a phase-contrast micrograph of 4th generation aggregate cells that were seeded to and cultured on the LG3-immobilized substrate for 3 d.
NPCs adhered and proliferated on the LG3-immobilized substrate as well as on the laminin-1-immobilized substrate. On the LG3-immobilized substrate, most of cells expressed nestin after 3 d of culture, while a few cells expressed -tubulin III (Fig. 5b) .
Overall, 98.3 ± 1.6% and 98.0 ± 0.1% of cells expressed nestin when cultured on the LG3-and laminin-1-immobilized substrates, respectively. Cell numbers increased 6-fold and 10-fold on LG3-and laminin-1-immobilized surfaces, respectively (Fig. 5c ). These increases were significantly higher than those determined for the control surface reacted with ethanolamine (no protein on the surface).
It was striking to observe that highly proliferative colonies occasionally formed on the laminin-1-immobilized substrate after 6 d of NPC culture (Fig. 6a) . Most cells in these colonies expressed GFP driven by the Nanog promoter (Fig. 6b) , indicating that these cells are in the undifferentiated state. In contrast, these colonies were not found on the LG3-immobilized substrate (Fig. 6 c and d) . This observation suggests that trace of undifferentiated miPS cells present in the 4th-generation aggregates were attached to and proliferated on the laminin-1-immobilized substrate, but not on the LG3-immobilized substrate. We examined this possibility by culturing undifferentiated miPS cells on the
LG3-and laminin-1-immobilized substrates. As shown in Fig. 6e , miPS cells adhered on the laminin-1-immobilized substrate and expanded approximately 5-fold within 3 d (Fig.   6g ). On the other hand, only a few miPS cells adhered on the LG3-immobilized substrate (Fig. 6f) , and the number of cells hardly increased on the LG3-immobilized substrate (Fig.   6gG ).
Discussion
Many protocols have been reported for the induction of NPCs from ES and iPS cells (Chambers et al., 2009; Cai, et al., 2007) . However, methods to efficiently expand NPCs derived from ES and iPS still remain to be developed for future clinical applications. In the present study, we differentiated miPS cells into NPCs in suspension (Okada. et al., 2008) .
During repeated subcultures, nestin-positive cells reached more than 70% of the total cells at the end of the 4th aggregate culture (Fig. 1) . However, there are still limitations associated with the suspension culture. The most critical problems may be heterogeneity of cell populations in an aggregates. The content of the rest of cells are more differentiated cells. In addition, cell death occur in a core of a large aggregate due to limited supplies of oxygen and nutrients.
To date, several research groups have examined various ECMs, such as Matrigel (Colleoni et al., 2010) , gelatin (Axell et al., 2009) , fibronectin (Hong et al., 2008) , and laminin (Koch et al., 2009 ) as culture substrates for NPCs. In the present study, nine ECM proteins were systematically examined using an array-based method. Except for laminin-5 18 the amounts of ECM proteins immobilized on an array were 0.3-0.5 μg/cm 2 . Although the amount of immobilized laminin-5 was at least 3-fold or so lower than the amounts of the other ECMs (Fig. 2) , we think that the amount of immobilized laminin-5 was sufficient for NPC proliferation. A density of closely packed laminin molecules in a two-dimensional lattice on a flat surface was estimated at 1 × 10 molecules. However, it is quite difficult to adjust surface molar concentration for different ECMs. As mentioned related to laminin-5, we expect sufficient amount of ECMs were immobilized on an array for NPC adhesion and proliferation. Using this analytical platform, we successfully found that NPCs derived from miPS cells proliferated most efficiently on substrates with laminin-1, laminin-5, or Matrigel. In contrast, NPC adhesion was poor on substrates with collagen I, collagen IV, or gelatin. These differences may be due to dissimilarities in the expression levels of integrins on the cell surface. It has been reported that NPCs derived from fetal brain tissue express integrin β1, α3, α6, and α7 and integrin complexes such as α3β1, α6β1, and α7β1, all of which constitute specific receptors for the laminins (Flanagan et al., 2006; Prowse et al., 2010) . On the other hand, the NPCs poorly expressed collagen-associated integrin α1, α2, α10, and α11 (Prowse et al., 2010) . In our previous study, neural stem cells derived from rat fetal brain also did not adhere on substrate with collagen I, collagen IV, and gelatin (Nakajima et al., 2007) .
From the clinical point of view, functional substrates used for cell preparation should be chemically defined, xeno-free, and low-cost. For these reasons, further investigations were conducted using laminin-derived small domains or short peptides that can partially replace the function of full-length laminin-1 (Ido et al., 2004; Tashiro et al., 1989) . In our previous study (Nakaji et al., 2012) , LG3 fused with a collagen-binding sequence was synthesized, and the engineered protein was incorporated in a collagen hydrogel to design a novel carrier for effective cell transplantation. The survival of rat neural stem cells was significantly improved in the LG3-incorporated collagen hydrogel due to effective integrin ligation, compared to a pure collagen hydrogel (Nakaji et al., 2012) . In the present study, we used LG3 fused with a His-tag and immobilized this polypeptide on a nickel-chelated glass plate to obtain a culture substrate. Although laminin-5 did well in NPC adhesion and proliferation at low density, we used LG3 derived from α chain of laminin-1. It is because laminin-1 has been widely studied and we can easily obtain information about threedimensional structure and physiological properties of the protein. NPCs adhered well and expanded rapidly on the LG3-immobilized substrate (Fig. 5) , although the rate of NPC proliferation on the LG3-immobilized substrate was slightly slower than that on the laminin-1-immobilized substrate. Approximately 98% of cells that expanded on the LG3-immobilized substrate expressed an NPC marker.
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For the clinical use of stem cells, the risk of tumor formation should be minimized as much as possible (Fong et al., 2010) . Undifferentiated pluripotent stem cells contaminating transplants may proliferate and overgrow in the host tissue (Li et al., 2008) . In the present study, the results of array-based screening indicated that laminin-1 served as a preferable substrate for the expansion of NPCs. However, undifferentiated miPS cells cells also proliferated to form colonies on the laminin-1-immobilized substrate (Fig. 6) . In contrast, undifferentiated miPS cells hardly attached and proliferated on the LG3-immobilized substrate ( Fig. 6 f and g ). The observed difference is probably due to distinct specificity of
LG3 and laminin-1 toward integrins. It is reported that LG3 domain binds most efficiently to α6β1 integrin (Belkin et al., 2000) , whereas laminin-1 has an affinity for a variety of integrin complexes (Durbeej 2010) . It is therefore likely that not only NPCs but also undifferentiated miPS cells are able to adhere to the substrate with immobilized laminin-1. Accordingly, we demonstrated here that the LG3-immobilized substrate is feasible for the selective proliferation of NPCs derived from miPS cells. However, several properties differ between human iPS cells and miPS cells (Yu et al., 2008) . Therefore, we are currently conducting further study to verify the effectiveness of the LG3-immobilized substrate for the selective expansion of NPCs derived from human iPS cells. Human NPCs highly express integrin α6 and β1 integrin (Prowse et al., 2010) . We think the LG3-immobilized substrate can be used for human NPC culture. 
